Holen Sie sich die Stockscreener-App
16.07
8.22%
-1.44
Handel nachbörslich:
17.25
1.18
+7.34%
Schlusskurs vom Vortag:
$17.51
Offen:
$17.5
24-Stunden-Volumen:
8,543
Relative Volume:
0.27
Marktkapitalisierung:
$153.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.12%
1M Leistung:
+21.10%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$16.07
$17.50
1-Wochen-Bereich:
$15.81
$18.87
52-Wochen-Spanne:
$10.00
$23.00
Invizyne Technologies Inc Stock (IZTC) Company Profile
Firmenname
Invizyne Technologies Inc
Sektor
Branche
Telefon
(626) - 415 - 1488
Adresse
750 ROYAL OAKS DR, MONROVIA
Vergleichen Sie IZTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IZTC
Invizyne Technologies Inc
|
16.07 | 153.41M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 120.86B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 77.62B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.62B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.20B | 3.30B | -501.07M | 1.03B | -2.1146 |
Invizyne Technologies Inc Aktie (IZTC) Neueste Nachrichten
Invizyne technologies CEO Michael Heltzen buys $20,345 in stock - MSN
Invizyne technologies CEO Michael Heltzen buys $20,345 in stock By Investing.com - Investing.com Australia
Investors on Edge! What Invizyne’s Market Entry Means for Biotech’s Future - Jomfruland.net
Invizyne Technologies Inc.'s (NASDAQ:IZTC) Quiet Period To End on December 23rd - MarketBeat
Invizyne Technologies Inc.’s Quiet Period Set To Expire on December 23rd (NASDAQ:IZTC) - Defense World
Invizyne Technologies selected for $2 million project to advance SAF capabilities - Biomass Magazine
Invizyne Technologies Inc trading halted, volatility trading pause - TipRanks
MDB Capital Holdings Provides Third Quarter 2024 Update - Marketscreener.com
Invizyne Technologies (IZTC) Income Statement & Balance Sheet 2024 - MarketBeat
Opening Day: Invizyne Technologies jumps after IPO - MSN
Invizyne technologies CEO acquires shares worth $22,022 By Investing.com - Investing.com Australia
Invizyne technologies CEO acquires shares worth $22,022 - Investing.com
Faculty in the News – James Bowie - UCLA – Chemistry and Biochemistry
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities - Marketscreener.com
Invizyne Technologies, Inc. Selects for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities - Marketscreener.com
Invizyne Technologies Completes IPO, Raises $14 Million in Net Proceeds - Defense World
Invizyne Technologies (IZTC) Stock Chart and Price History 2024 - MarketBeat
U.S. IPO Weekly Recap: One Micro-Cap Lists And More Enter Pipeline, As Peak Resources Postpones Its IPO - Seeking Alpha
Invizyne Technologies Announces Closing of Initial Public Offering - Marketscreener.com
Invizyne Technologies Completes $15M IPO, Makes NASDAQ Debut Under IZTC | MDBH Stock News - StockTitan
Invizyne Technologies stock climbs 13% following $15M IPO - MSN
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing - GlobeNewswire
Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing - Quantisnow
Invizyne Technologies Opens At $11.10, IPO Priced At $8 By Investing.com - Investing.com Canada
Invizyne Technologies Begins Trading on NASDAQ - GlobeNewswire
Invizyne Technologies prices $15M U.S. IPO - MSN
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024 - The Bakersfield Californian
Invizyne Technologies prices $15M U.S. IPO (Pending:IZTC.) - Seeking Alpha
Invizyne Technologies Launches $15M IPO, Sets Nasdaq Debut Under 'IZTC' Symbol | MDBH Stock News - StockTitan
TSX Health Care Capped Index (TTHC) QuotePress Release - The Globe and Mail
ULSD NY Harbor (HON24) Quote - The Globe and Mail
IZTC IPO NewsBiomanufacturing company Invizyne Technologies revises terms ahead of $15 million IPO - Renaissance Capital
Biomanufacturing company Invizyne Technologies cuts share offering by 13% and adds rights ahead of $15 million IPO - Renaissance Capital
The cold truth: B100 with Optimus Technologies work at -30 °F - Biodiesel Magazine
MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies - GlobeNewswire
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq - GlobeNewswire
MDB Capital Holdings Year-End Update - GlobeNewswire
Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq - GlobeNewswire
Michael Burns Joins Invizyne as Executive Vice President of Energy Transition - GlobeNewswire
Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort - GlobeNewswire
Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy - GlobeNewswire
MDBHMDB Capital Holdings, LLC Latest Stock News & Market Updates - StockTitan
Japan plans to implement SAF mandate by 2030 - Biodiesel Magazine
Cavitation Technologies to supply LPN system to biodiesel plant - Biodiesel Magazine
Haldor Topsoe technology to be installed at 2 SAF biorefineries - Biodiesel Magazine
Major advance in biochemistry holds promise for biofuels - University of California
Major advance in ‘synthetic biochemistry’ holds promise for industrial products and biofuels - UCLA Newsroom
Finanzdaten der Invizyne Technologies Inc-Aktie (IZTC)
Es liegen keine Finanzdaten für Invizyne Technologies Inc (IZTC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Invizyne Technologies Inc-Aktie (IZTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Heltzen Michael | Chief Executive Officer |
Jan 16 '25 |
Buy |
10.72 |
121 |
1,297 |
2,105 |
| Heltzen Michael | Chief Executive Officer |
Nov 15 '24 |
Buy |
11.10 |
1,984 |
22,022 |
1,984 |
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):